Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Lo

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Acta Astronautica|December 3, 2003
Innovations in mission architectures for exploration beyond low Earth orbitD R Cooke, B J Joosten, M W Lo, et al.
The Journal of Clinical Psychiatry|September 1, 1984
Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administrationM C Meyer, A B Straughn, M W Lo, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 24, 2006
A treatable case of dementia--intracranial dural arteriovenous fistulaH Y Chan, K M Cheng, M W Lo, et al.
Clinical Pharmacology and Therapeutics|December 1, 1995
Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humansM W Lo, M R Goldberg, J B McCrea, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1984
Nonlinear formation of propranolol metabolites in dogs after portacaval transpositionsM W Lo, S M Pond, D J Effeney, et al.
Biopharmaceutics & Drug Disposition|August 28, 2001
Pharmacokinetic assessment of an oral enalapril suspension for use in childrenR K Rippley, J Connor, J Boyle, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Phenobarbital minimally alters plasma concentrations of losartan and its active metabolite E-3174M R Goldberg, M W Lo, P J Deutsch, et al.
European Journal of Clinical Pharmacology|July 29, 1999
Lack of polymorphism of the conversion of losartan to its active metabolite E-3174 in extensive and poor metabolizers of debrisoquine (cytochrome P450 2D6) and mephenytoin (cytochrome P450 2C19)P Sandwall, M W Lo, B Jonzon, et al.
Journal of Clinical Pharmacology|December 1, 1995
Absence of a pharmacokinetic interaction between losartan and hydrochlorothiazideJ B McCrea, M W Lo, L Tomasko, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1993
Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteersM R Goldberg, W Tanaka, A Barchowsky, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Acta Astronautica|December 3, 2003
Innovations in mission architectures for exploration beyond low Earth orbitD R Cooke, B J Joosten, M W Lo, et al.
The Journal of Clinical Psychiatry|September 1, 1984
Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administrationM C Meyer, A B Straughn, M W Lo, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 24, 2006
A treatable case of dementia--intracranial dural arteriovenous fistulaH Y Chan, K M Cheng, M W Lo, et al.
Clinical Pharmacology and Therapeutics|December 1, 1995
Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humansM W Lo, M R Goldberg, J B McCrea, et al.
Journal of Pharmacokinetics and Biopharmaceutics|August 1, 1984
Nonlinear formation of propranolol metabolites in dogs after portacaval transpositionsM W Lo, S M Pond, D J Effeney, et al.
Biopharmaceutics & Drug Disposition|August 28, 2001
Pharmacokinetic assessment of an oral enalapril suspension for use in childrenR K Rippley, J Connor, J Boyle, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Phenobarbital minimally alters plasma concentrations of losartan and its active metabolite E-3174M R Goldberg, M W Lo, P J Deutsch, et al.
European Journal of Clinical Pharmacology|July 29, 1999
Lack of polymorphism of the conversion of losartan to its active metabolite E-3174 in extensive and poor metabolizers of debrisoquine (cytochrome P450 2D6) and mephenytoin (cytochrome P450 2C19)P Sandwall, M W Lo, B Jonzon, et al.
Journal of Clinical Pharmacology|December 1, 1995
Absence of a pharmacokinetic interaction between losartan and hydrochlorothiazideJ B McCrea, M W Lo, L Tomasko, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1993
Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteersM R Goldberg, W Tanaka, A Barchowsky, et al.
Pageof 5